scholarly article | Q13442814 |
P356 | DOI | 10.1016/0002-9378(91)90012-G |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:000293789190012G?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:000293789190012G?httpAccept=text/xml | ||
P698 | PubMed publication ID | 1750458 |
P2093 | author name string | E. A. Sims | |
S. B. Amini | |||
P. M. Catalano | |||
E. D. Tyzbir | |||
N. M. Roman | |||
P2860 | cites work | Criteria for screening tests for gestational diabetes | Q34057052 |
Glucose clamp technique: a method for quantifying insulin secretion and resistance | Q34191986 | ||
Metabolic adjustments in normal and diabetic pregnancy. | Q40303119 | ||
The insulin response to glucose infusion in normal human pregnancy | Q41614061 | ||
Evidence for marked sensitivity to the antilipolytic action of insulin in obese maturity-onset diabetics | Q41642932 | ||
Fetal glucose metabolism and oxygen consumption during sustained hypoglycemia | Q45582647 | ||
The effect of parity on the later development of non-insulin-dependent diabetes mellitus or impaired glucose tolerance. | Q46019514 | ||
Effects of childbearing on glucose tolerance and NIDDM prevalence. | Q51614919 | ||
Insulin sensitivity and B-cell responsiveness to glucose during late pregnancy in lean and moderately obese women with normal glucose tolerance or mild gestational diabetes. | Q54327144 | ||
Subclinical abnormalities of glucose metabolism in subjects with previous gestational diabetes. | Q54418847 | ||
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group | Q66972631 | ||
Intravenous glucose tolerance test and its modification by pregnancy | Q71448348 | ||
PLASMA INSULIN IN NORMAL MIDPREGNANCY | Q78312511 | ||
Further observations on reactivity to insulin in normal pregnancy | Q78615288 | ||
Plasma insulin in normal late pregnancy | Q79672529 | ||
P433 | issue | 6 Pt 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | human pregnancy | Q11995 |
insulin resistance | Q1053470 | ||
preproinsulin | Q7240673 | ||
pregnant person | Q104720811 | ||
P304 | page(s) | 1667-1672 | |
P577 | publication date | 1991-12-01 | |
P1433 | published in | American Journal of Obstetrics and Gynecology | Q4744256 |
P1476 | title | Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women | |
P478 | volume | 165 |
Q37683905 | A case of a woman with late-pregnancy-onset DKA who had normal glucose tolerance in the first trimester |
Q46789421 | Acute exercise increases insulin sensitivity in adult sheep: a new preclinical model |
Q30496377 | Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy |
Q90419411 | Adherence to the Mediterranean Diet and Serum Adiponectin Levels in Pregnancy: Results from a Cohort Study in Normal Weight Caucasian Women |
Q46854306 | Adiponectin Deficiency Impairs Maternal Metabolic Adaptation to Pregnancy in Mice. |
Q46567506 | Adiponectin concentrations in maternal serum: elevated in preeclampsia but unrelated to insulin sensitivity |
Q37311261 | Adiponectin multimers in maternal plasma. |
Q51196334 | Adipose Tissue Insulin Resistance in Gestational Diabetes. |
Q44536243 | Aerobic conditioning effects on substrate responses during graded cycling in pregnancy |
Q37035990 | Age at birth of first child and coronary heart disease risk factors at age 53 years in men and women: British birth cohort study |
Q36436400 | Are the metabolic changes of pregnancy reversible in the first year postpartum? |
Q37198235 | Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice |
Q58576970 | Association between Gestational Weight Gain, Gestational Diabetes Risk, and Obstetric Outcomes: A Randomized Controlled Trial Post Hoc Analysis |
Q35542792 | Association of oxidative stress biomarkers with gestational diabetes mellitus in pregnant women: a case-control study |
Q84561533 | Beta cell adaptation in pregnancy: a major difference between humans and rodents? |
Q35035230 | Beta-cell ARNT is required for normal glucose tolerance in murine pregnancy |
Q90320712 | Breastfeeding Duration and the Risk of Coronary Artery Disease |
Q36926968 | Carbohydrate intake as a risk factor for biliary sludge and stones during pregnancy |
Q40283588 | Carbohydrate intake during early pregnancy is inversely associated with abnormal glucose challenge test results in Japanese pregnant women. |
Q92360783 | Changes in insulin requirements during pregnancy in Japanese women with type 1 diabetes |
Q43500277 | Changes of insulin resistance and β-cell function in women with gestational diabetes mellitus and normal pregnant women during mid- and late pregnant period: a case-control study |
Q36741984 | Chronic estradiol and progesterone treatment in conscious dogs: effects on insulin sensitivity and response to hypoglycemia |
Q48261115 | Chronic hyperandrogenemia and western-style diet beginning at puberty reduces fertility and increases metabolic dysfunction during pregnancy in young adult, female macaques. |
Q97075291 | Comparison of Machine Learning Methods and Conventional Logistic Regressions for Predicting Gestational Diabetes Using Routine Clinical Data: A Retrospective Cohort Study |
Q57292609 | Concise Review: The Current State of Human in vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue Engineering |
Q36109241 | Convergence in insulin resistance between very severely obese and lean women at the end of pregnancy. |
Q74108333 | Diabetes in pregnancy |
Q73899237 | Diabetic ketoacidosis in pregnancy |
Q46865904 | Dietary intake, capillary blood glucose, and activity level of activity-restricted, hospitalized, pregnant women in the third trimester: a pilot study. |
Q48500696 | Digital blood glucose monitoring could provide new objective assessments of blood glucose control in women with gestational diabetes |
Q46710236 | Do adiponectin, TNFalpha, leptin and CRP relate to insulin resistance in pregnancy? Studies in women with and without gestational diabetes, during and after pregnancy |
Q42485619 | Does parity increase insulin resistance during pregnancy? |
Q90210722 | Drugs to Control Diabetes During Pregnancy |
Q26782582 | ENDOCRINOLOGY OF PREGNANCY: Gestational diabetes mellitus: definition, aetiological and clinical aspects |
Q37454975 | Early Diagnosis of Gestational Diabetes Mellitus (EDoGDM) study: a protocol for a prospective, longitudinal cohort study |
Q38946988 | Early Pregnancy Biochemical Predictors of Gestational Diabetes Mellitus |
Q35998333 | Effect of dietary and lifestyle factors on the risk of gestational diabetes: review of epidemiologic evidence |
Q37596677 | Effect of preeclampsia on insulin sensitivity |
Q77919749 | Effect of reduced inspired oxygen on fetal growth and maternal glucose metabolism in rat pregnancy |
Q34308045 | Effects of a low-glycemic load diet in overweight and obese pregnant women: a pilot randomized controlled trial |
Q39763603 | Elevated insulin sensitivity and β-cell function during pregnancy in mothers of growth-restricted newborns |
Q36699160 | Environmental factors in the development of Type 1 diabetes |
Q92048446 | Epicardial adipose tissue thickness as a potential predictor of gestational diabetes mellitus: a prospective cohort study |
Q33683594 | Estimates of insulin sensitivity using glucose and C-Peptide from the hyperglycemia and adverse pregnancy outcome glucose tolerance test |
Q45007070 | Evaluation of the serum leptin in normal pregnancy and gestational diabetes mellitus in Zahedan, southeast Iran |
Q51562134 | Evidence of a state of increased insulin resistance in preeclampsia. |
Q24541507 | Evolution of the mammalian placenta revealed by phylogenetic analysis |
Q34524187 | Exercise and pregnancy in recreational and elite athletes: 2016 evidence summary from the IOC expert group meeting, Lausanne. Part 1-exercise in women planning pregnancy and those who are pregnant. |
Q36825630 | Exercise, pregnancy, and insulin sensitivity--what is new? |
Q48624760 | Expression of insulin-receptor substrate-1 and -2 in ovaries from women with insulin resistance and from controls |
Q88012931 | Fibroblast growth factor 21 expressions in white blood cells and sera of patients with gestational diabetes mellitus during gestation and postpartum |
Q46745535 | First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy |
Q51008995 | First-trimester adiponectin and subsequent development of preeclampsia or fetal growth restriction. |
Q35179348 | Free fatty acids, insulin resistance, and pregnancy |
Q44452041 | From infancy to pregnancy: birth weight, body mass index, and the risk of gestational diabetes |
Q41018365 | Fuel metabolism in pregnancy and in gestational diabetes mellitus |
Q92703167 | GDM and Nutrition-Answered and Unanswered Questions-There's More Work to Do! |
Q35223931 | Genetic and environmental determinants of non‐insulin‐dependent diabetes mellitus (NIDDM) |
Q33683791 | Gestational diabetes mellitus |
Q87029193 | Gestational diabetes mellitus |
Q91809506 | Gestational diabetes mellitus |
Q38875540 | Gestational diabetes mellitus: does an effective prevention strategy exist? |
Q37185944 | Gestational diabetes: emerging concepts in pathophysiology |
Q36724813 | Hepatic and muscle insulin action during late pregnancy in the dog. |
Q36635289 | Hepatic glucose metabolism in late pregnancy: normal versus high-fat and -fructose diet |
Q46882464 | High Fasting Plasma Glucose during Early Pregnancy: A Review about Early Gestational Diabetes Mellitus. |
Q52741473 | High Prevalence of Diabetes-Predisposing Variants in MODY Genes Among Danish Women With Gestational Diabetes Mellitus. |
Q36428121 | Identification of early transcriptome signatures in placenta exposed to insulin and obesity |
Q92622729 | Impaired early-phase suppression of glucagon secretion after glucose load is associated with insulin requirement during pregnancy in gestational diabetes |
Q46517545 | Increased lipolysis in non-obese pregnant women studied in the third trimester |
Q42791966 | Increased serum retinol-binding protein-4 levels in pregnant women with and without gestational diabetes mellitus |
Q26799252 | Indicators of glycemic control in patients with gestational diabetes mellitus and pregnant women with diabetes mellitus |
Q51536496 | Influence of leptin and the TNF system on insulin resistance in pregnancy and their effect on anthropometric parameters of newborns |
Q90636696 | Influence of litter size on insulin sensitivity in multiparous sows |
Q44746393 | Insulin action during late pregnancy in the conscious dog. |
Q44979520 | Insulin resistance and pre-eclampsia: a role for tumor necrosis factor-alpha? |
Q45103752 | Insulin resistance is a risk factor for progression to type 1 diabetes |
Q37565702 | Insulin resistance: the possible link between gestational diabetes mellitus and hypertensive disorders of pregnancy |
Q35184288 | Intermediate metabolism in normal pregnancy and in gestational diabetes. |
Q51712674 | Intrafetal glucose infusion alters glucocorticoid signaling and reduces surfactant protein mRNA expression in the lung of the late-gestation sheep fetus. |
Q51046224 | Intrauterine Growth Restricted Rats Exercised at Pregnancy: Maternal-Fetal Repercussions. |
Q92137571 | Is preeclampsia itself a risk factor for the development of metabolic syndrome after delivery? |
Q37133291 | Lactation and Maternal Cardio-Metabolic Health |
Q38319858 | Leptin concentrations in maternal serum and amniotic fluid during the second trimenon: differential relation to fetal gender and maternal morphometry |
Q57606231 | Lipoprotein metabolism and vascular complications in pregnancy |
Q47645121 | Long non-coding RNA MALAT1 expression in patients with gestational diabetes mellitus |
Q46451754 | Long-term diabetogenic effect of single pregnancy in women with previous gestational diabetes mellitus |
Q50279581 | Long-term testosterone treatment during pregnancy does not alter insulin or glucose profile in a sheep model of polycystic ovary syndrome |
Q51604070 | Longitudinal changes in basal hepatic glucose production and suppression during insulin infusion in normal pregnant women |
Q77326032 | Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus |
Q38132102 | Management of reproduction and pregnancy complications in maternal obesity: which role for dietary polyphenols? |
Q100501047 | Maternal Pineal Melatonin in Gestation and Lactation Physiology, and in Fetal Development and Programming |
Q46653118 | Maternal Serum Resistin Is Reduced in First Trimester Preeclampsia Pregnancies and Is a Marker of Clinical Severity |
Q26865194 | Maternal cardiac metabolism in pregnancy |
Q35134214 | Maternal factors that determine neonatal size and body fat. |
Q24604436 | Maternal metabolism and obesity: modifiable determinants of pregnancy outcome |
Q79686699 | Maternal serum adiponectin levels during human pregnancy |
Q36406577 | Maternal visfatin concentration in normal pregnancy |
Q51493299 | Metabolic disorders in patients with recent gestational diabetes mellitus. |
Q51319697 | Metabolic effects of lifestyle intervention in obese pregnant women. Results from the randomized controlled trial 'Lifestyle in Pregnancy' (LiP). |
Q39395469 | Metabolomics of Diabetes in Pregnancy |
Q22242884 | Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications |
Q46955555 | Metformin use and diabetic pregnancy-has its time come? |
Q90296053 | Mild Maternal Obstructive Sleep Apnea in Non-obese Pregnant Women and Accelerated Fetal Growth |
Q36312445 | Molecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy |
Q47932349 | Myo-inositol may prevent gestational diabetes onset in overweight women: a randomized, controlled trial |
Q53813100 | No effect of modest selenium supplementation on insulin resistance in UK pregnant women, as assessed by plasma adiponectin concentration. |
Q34266088 | Obesity, insulin resistance, and pregnancy outcome |
Q61453798 | Osteocalcin Serum Levels in Gestational Diabetes Mellitus and Their Intrinsic and Extrinsic Determinants: Systematic Review and Meta-Analysis |
Q33990127 | Overweight and Obesity before, during and after Pregnancy: Part 1: Pathophysiology, Molecular Biology and Epigenetic Consequences |
Q34451749 | Pathogenesis of type 2 diabetes. Insulin resistance |
Q34130942 | Patterns of adiponectin expression in term pregnancy: impact of obesity |
Q31018690 | Physical activity, sedentary behaviors, and estimated insulin sensitivity and secretion in pregnant and non-pregnant women |
Q46239763 | Plant stanol ester spreads as components of a balanced diet for pregnant and breast-feeding women: evaluation of clinical safety |
Q36696378 | Plasma adiponectin concentrations in non-pregnant, normal and overweight pregnant women. |
Q57812361 | Poor Sleep Quality Is Associated with Higher Hemoglobin A1c in Pregnant Women: A Pilot Observational Study |
Q91815900 | Pre-eclampsia: pathogenesis, novel diagnostics and therapies |
Q87054690 | Predicting gestational diabetes mellitus during the first trimester using anthropometric measurements and HOMA-IR |
Q37675831 | Prediction of Gestational Diabetes Mellitus by Unconjugated Estriol Levels in Maternal Serum |
Q51314763 | Prediction of gestational diabetes mellitus in the first trimester: comparison of C-reactive protein, fasting plasma glucose, insulin and insulin sensitivity indices. |
Q77098028 | Pregnancy in diabetes |
Q90098350 | Prevalence of gestational diabetes mellitus and associated factors among women attending antenatal care at Gondar town public health facilities, Northwest Ethiopia |
Q47097096 | Preventing cardiovascular disease after hypertensive disorders of pregnancy: Searching for the how and when. |
Q38479819 | Prevention of gestational diabetes mellitus: Where are we now? |
Q43260783 | Relationship between maternal growth, infant birthweight and nutrient partitioning in teenage pregnancies |
Q36699860 | Resistin: a hormone which induces insulin resistance is increased in normal pregnancy. |
Q36302354 | Resveratrol ameliorates the chemical and microbial induction of inflammation and insulin resistance in human placenta, adipose tissue and skeletal muscle |
Q37497870 | Reviews: adipocytokines in normal and complicated pregnancies |
Q50049274 | Rhythmic Three-Part Harmony: The Complex Interaction of Maternal, Placental and Fetal Circadian Systems |
Q33759053 | Rising maternal circulating GH during murine pregnancy suggests placental regulation |
Q35895869 | Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus |
Q38715516 | Sedentary behavior, gestational diabetes mellitus, and type 2 diabetes risk: where do we stand? |
Q90458316 | Serum irisin levels as a potential marker for diagnosis of gestational diabetes mellitus |
Q36303197 | Sex hormone binding globulin as a valuable biochemical marker in predicting gestational diabetes mellitus |
Q50131253 | Socioeconomic Status and Care Metrics for Women Diagnosed With Gestational Diabetes Mellitus |
Q38339936 | Study on pancreatic islet adaptation and gene expression during pregnancy in rats |
Q44349432 | Testosterone levels in pregnant women correlate with the insulin response during the glucose tolerance test. |
Q58114519 | The Pathophysiology of Gestational Diabetes Mellitus |
Q59800803 | The Role of Irisin, Insulin and Leptin in Maternal and Fetal Interaction |
Q87627368 | The impact of gestational diabetes and maternal obesity on the mother and her offspring |
Q73947927 | The incidence of pregnancy-induced hypertension among patients with carbohydrate intolerance |
Q47099455 | The prevalence of elevated high-sensitivity C-reactive protein in normal pregnancy and gestational diabetes mellitus |
Q47701882 | The receptor for advanced glycation end products (RAGE) is elevated in women with preeclampsia |
Q48019072 | The relationship between insulin and insulin-like growth factor binding protein-1 is modified by pre-eclampsia |
Q38155672 | The role of exercise in reducing the risks of gestational diabetes mellitus |
Q47795458 | Third trimester abnormal oral glucose tolerance test and adverse perinatal outcome |
Q43915933 | Tumor necrosis factor system in insulin resistance in gestational diabetes. |
Q61964211 | UPBEAT, RADIEL, and DALI: what's the difference? |
Q46421990 | Urinary Excretion of Myo-Inositol and D-Chiro-Inositol in Early Pregnancy Is Enhanced in Gravidas With Gestational Diabetes Mellitus |
Q36419240 | Visfatin in human pregnancy: maternal gestational diabetes vis-à-vis neonatal birthweight |
Q42772087 | When should we screen for gestational diabetes? |
Search more.